Halford S - Search Results

1

Expression of the multidrug resistance gene in human prostate cancer.

Bhangal G, Halford S, Wang J, Roylance R, Shah R, Waxman J. Bhangal G, et al. Among authors: halford s. Urol Oncol. 2000 Apr 1;5(3):118-121. doi: 10.1016/s1078-1439(99)00055-1. Urol Oncol. 2000. PMID: 10765019

2

The management of carcinoid tumours.

Halford S, Waxman J. Halford S, et al. QJM. 1998 Dec;91(12):795-8. doi: 10.1093/qjmed/91.12.795. QJM. 1998. PMID: 10024944 Review. No abstract available.

3

Adjuvant mitozantrone chemotherapy in advanced prostate cancer.

Wang J, Halford S, Rigg A, Roylance R, Lynch M, Waxman J. Wang J, et al. Among authors: halford s. BJU Int. 2000 Oct;86(6):675-80. doi: 10.1046/j.1464-410x.2000.00894.x. BJU Int. 2000. PMID: 11069375 Clinical Trial.

4

SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.

Woodford-Richens KL, Rowan AJ, Gorman P, Halford S, Bicknell DC, Wasan HS, Roylance RR, Bodmer WF, Tomlinson IP. Woodford-Richens KL, et al. Among authors: halford s. Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9719-23. doi: 10.1073/pnas.171321498. Epub 2001 Jul 31. Proc Natl Acad Sci U S A. 2001. PMID: 11481457 Free PMC article.

5

MSI-low, a real phenomenon which varies in frequency among cancer types.

Halford SE, Sawyer EJ, Lambros MB, Gorman P, Macdonald ND, Talbot IC, Foulkes WD, Gillett CE, Barnes DM, Akslen LA, Lee K, Jacobs IJ, Hanby AM, Ganesan TS, Salvesen HB, Bodmer WF, Tomlinson IP, Roylance RR. Halford SE, et al. J Pathol. 2003 Nov;201(3):389-94. doi: 10.1002/path.1453. J Pathol. 2003. PMID: 14595750

6

Array-CGH analysis of microsatellite-stable, near-diploid bowel cancers and comparison with other types of colorectal carcinoma.

Jones AM, Douglas EJ, Halford SE, Fiegler H, Gorman PA, Roylance RR, Carter NP, Tomlinson IP. Jones AM, et al. Oncogene. 2005 Jan 6;24(1):118-29. doi: 10.1038/sj.onc.1208194. Oncogene. 2005. PMID: 15531920

7

Project Optimus, an FDA initiative: Considerations for cancer drug development internationally, from an academic perspective.

Murphy R, Halford S, Symeonides SN. Murphy R, et al. Among authors: halford s. Front Oncol. 2023 Mar 3;13:1144056. doi: 10.3389/fonc.2023.1144056. eCollection 2023. Front Oncol. 2023. PMID: 36937434 Free PMC article.

8

CDX2 mutations do not account for juvenile polyposis or Peutz-Jeghers syndrome and occur infrequently in sporadic colorectal cancers.

Woodford-Richens KL, Halford S, Rowan A, Bevan S, Aaltonen LA, Wasan H, Bicknell D, Bodmer WF, Houlston RS, Tomlinson IP. Woodford-Richens KL, et al. Among authors: halford s. Br J Cancer. 2001 May 18;84(10):1314-6. doi: 10.1054/bjoc.2001.1800. Br J Cancer. 2001. PMID: 11355940 Free PMC article.

9

Low-level microsatellite instability occurs in most colorectal cancers and is a nonrandomly distributed quantitative trait.

Halford S, Sasieni P, Rowan A, Wasan H, Bodmer W, Talbot I, Hawkins N, Ward R, Tomlinson I. Halford S, et al. Cancer Res. 2002 Jan 1;62(1):53-7. Cancer Res. 2002. PMID: 11782358

10

Does MSI-low exist?

Tomlinson I, Halford S, Aaltonen L, Hawkins N, Ward R. Tomlinson I, et al. Among authors: halford s. J Pathol. 2002 May;197(1):6-13. doi: 10.1002/path.1071. J Pathol. 2002. PMID: 12081205 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

280 results

Search Page